Although virus load testing is anticipated to eclipse CD4 counts in long-term monitoring, at present CD4 testing at POC with rapid turn-around time informs opportunistic infections prophylaxis, ART management and may guide switching to second line therapy or prompt targeted virus load testing[7, 34]. The gene discussed is CD4; the disease is Opportunistic infection.